|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,678.25 DKK | +1.16% |
|
-3.23% | -17.12% |
| 12:05pm | Nordea resumes coverage of Genmab with Buy rating and DKK 2,015 price target | FW |
| 11/05 | Deutsche Bank trims Genmab price target to DKK 2,250 (2,400), reiterates Buy | FW |
MarketScreener Strategies
Search
 | Genmab: Market mispricing creates opportunity as good Q1 reinforces investment thesis | May 09, 2026 at 05:35 pm IST |
| Genmab: 2025 miss and cautious 2026 targets erode investor confidence | February 18, 2026 at 07:39 pm IST |
| Genmab advances on earnings strength and pipeline while lower valuation opens upside | November 07, 2025 at 08:31 pm IST |
| Genmab: A bold shift from defensive to aggressive | September 29, 2025 at 08:15 pm IST |
 | Genmab: From now on, courage to the most patient | April 01, 2025 at 08:27 pm IST |
No results for this search
Filters
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition